SecBot SecBot
8-K ·Filed May 29, 2026

ANAB

ANAPTYSBIO, INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001193125-26-248326
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

No trading signal. The filing is purely informational regarding tax treatment of a prior spin-off. Monitor for any subsequent operational updates from AnaptysBio or First Tracks.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$53.14
T+0 close · May 29, 2026 · via day close
Latest settled
+9.84%
T+60 · $58.37
Vs SPY
+8.61%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $53.14entry
  2. T+1 · 6mo ago −3.54%α −3.69% · $51.26
  3. T+5 · 5mo ago −5.21%α −2.46% · $50.37
  4. T+20 · 5mo ago +27.02%α +28.32% · $67.50
  5. T+60 · 3mo ago +9.84%α +8.61% · $58.37
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AnaptysBio filed an 8-K under Item 7.01 to disclose that it has filed Form 8937 with the IRS regarding the tax treatment of the spin-off of First Tracks Biotherapeutics, Inc. The filing provides stockholders with information on how the dividend is treated for tax purposes and how to adjust their tax basis. This is a routine administrative disclosure with no new financial or operational information.

Key Facts

  • AnaptysBio filed Form 8937 with the IRS related to the separation and spin-off of First Tracks Biotherapeutics, Inc.
  • The Form 8937 provides guidance on tax treatment of the dividend and change in tax basis for stockholders.
  • The information is furnished under Regulation FD and is not deemed filed for Exchange Act purposes.

Financial Impact

No financial figures disclosed; tax-basis guidance only.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-248326
Document: 0001193125-26-248326-index-headers.html0001193125-26-248326
Document: 0001193125-26-248326-index.html0001193125-26-248326
Document: 0001193125-26-248326.txt0001193125-26-248326

Track record

28 reports on ANAB

Performance horizon

10 of 19 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 19 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026